A detailed history of Aries Wealth Management transactions in Editas Medicine, Inc. stock. As of the latest transaction made, Aries Wealth Management holds 13,850 shares of EDIT stock, worth $18,143. This represents 0.0% of its overall portfolio holdings.

Number of Shares
13,850
Previous 13,850 -0.0%
Holding current value
$18,143
Previous $47,000 63.83%
% of portfolio
0.0%
Previous 0.01%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 25, 2024

BUY
$4.67 - $7.28 $64,679 - $100,828
13,850 New
13,850 $64,000
Q4 2021

Jan 18, 2022

BUY
$26.55 - $40.57 $743,400 - $1.14 Million
28,000 New
28,000 $743,000
Q3 2021

Oct 13, 2021

SELL
$39.27 - $72.94 $157,080 - $291,760
-4,000 Closed
0 $0
Q2 2021

Jul 14, 2021

BUY
$31.29 - $56.64 $125,160 - $226,560
4,000 New
4,000 $227,000
Q1 2021

Apr 20, 2021

SELL
$39.71 - $90.58 $158,840 - $362,320
-4,000 Closed
0 $0
Q4 2020

Jan 22, 2021

BUY
$27.07 - $84.35 $108,280 - $337,400
4,000 New
4,000 $362,000

Others Institutions Holding EDIT

About Editas Medicine, Inc.


  • Ticker EDIT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 68,737,200
  • Market Cap $90M
  • Description
  • Editas Medicine, Inc., a clinical stage genome editing company, focuses on developing transformative genomic medicines to treat a range of serious diseases. It develops a proprietary gene editing platform based on CRISPR technology. The company develops EDIT-101, which is in Phase 1/2 clinical trial for Leber Congenital Amaurosis 10 that leads t...
More about EDIT
Track This Portfolio

Track Aries Wealth Management Portfolio

Follow Aries Wealth Management and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Aries Wealth Management, based on Form 13F filings with the SEC.

News

Stay updated on Aries Wealth Management with notifications on news.